Related references
Note: Only part of the references are listed.Systematic Review of the Therapeutic Efficacy of Bladder-preserving Treatments for Non-muscle-invasive Bladder Cancer Following Intravesical Bacillus Calmette-Guerin
Roger Li et al.
EUROPEAN UROLOGY (2020)
Intravesical Ty21a Vaccine Promotes Dendritic Cells and T Cell-Mediated Tumor Regression in the MB49 Bladder Cancer Model
Sonia Domingos-Pereira et al.
CANCER IMMUNOLOGY RESEARCH (2019)
Mechanisms of BCG immunotherapy and its outlook for bladder cancer
Caroline Pettenati et al.
NATURE REVIEWS UROLOGY (2018)
Patient Compliance With Maintenance Intravesical Therapy for Nonmuscle Invasive Bladder Cancer
Shlomi Tapiero et al.
UROLOGY (2018)
Preclinical efficacy and safety of the Ty21a vaccine strain for intravesical immunotherapy of non-muscle-invasive bladder cancer
Sonia Domingos-Pereira et al.
ONCOIMMUNOLOGY (2017)
EAU Guidelines on Non-Muscle-invasive Urothelial Carcinoma of the Bladder: Update 2016
Marko Babjuk et al.
EUROPEAN UROLOGY (2017)
A Multimodal Imaging Approach for Longitudinal Evaluation of Bladder Tumor Development in an Orthotopic Murine Model
Chantal Scheepbouwer et al.
PLOS ONE (2016)
Poly Peak Parser: Method and Software for Identification of Unknown Indels Using Sanger Sequencing of Polymerase Chain Reaction Products
Jonathon T. Hill et al.
DEVELOPMENTAL DYNAMICS (2014)
Side Effects of Bacillus Calmette-Guerin (BCG) in the Treatment of Intermediate- and High-risk Ta, T1 Papillary Carcinoma of the Bladder: Results of the EORTC Genito-Urinary Cancers Group Randomised Phase 3 Study Comparing One-third Dose with Full Dose and 1 Year with 3 Years of Maintenance BCG
Maurizio Brausi et al.
EUROPEAN UROLOGY (2014)
Structural Analysis and Optimization of the Covalent Association between SpyCatcher and a Peptide Tag
Long Li et al.
JOURNAL OF MOLECULAR BIOLOGY (2014)
An autotransporter display platform for the development of multivalent recombinant bacterial vector vaccines
Wouter S. P. Jong et al.
MICROBIAL CELL FACTORIES (2014)
In vitro intestinal mucosal epithelial responses to wild-type Salmonella Typhi and attenuated typhoid vaccines
Maria Fiorentino et al.
FRONTIERS IN IMMUNOLOGY (2013)
Peptide tag forming a rapid covalent bond to a protein, through engineering a bacterial adhesin
Bijan Zakeri et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2012)
An Individual Patient Data Meta-Analysis of the Long-Term Outcome of Randomised Studies Comparing Intravesical Mitomycin C versus Bacillus Calmette-Guerin for Non-Muscle-Invasive Bladder Cancer
Per-Uno Malmstrom et al.
EUROPEAN UROLOGY (2009)
Distinct glycan structures of uroplakins Ia and Ib - Structural basis for the selective binding of FimH adhesin to uroplakin Ia
Bo Xie et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2006)
Predicting recurrence and progression in individual patients with stage Ta T1 bladder cancer using EORTC risk tables: A combined analysis of 2596 patients from seven EORTC trials
RJ Sylvester et al.
EUROPEAN UROLOGY (2006)
Maintenance bacillus Calmette-Guerin immunotherapy for recurrent Ta, T1 and carcinoma in situ transitional cell carcinoma of the bladder: A randomized Southwest Oncology Group study
DL Lamm et al.
JOURNAL OF UROLOGY (2000)
Share Paper
